Tech Company Financing Transactions
Bellicum Pharmaceuticals Funding Round
AVG Ventures, Remeditex Ventures and private investors participated in a $34.4 million Series B venture round for Bellicum Pharmaceuticals. The funding round was announced on 1/8/2014.
Transaction Overview
Company Information
Houston, TX 77030
USA
Management Team
Browse more venture capital transactions:
Prev: 1/8/2014: Oscar Health venture capital transaction
Next: 1/8/2014: Actinium Pharmaceuticals venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs